Optiscan Imaging Ltd (OIL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Optiscan Imaging Ltd (OIL) has a cash flow conversion efficiency ratio of -0.188x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-4.13 Million ≈ $-2.92 Million USD) by net assets (AU$22.02 Million ≈ $15.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see OIL stock market capitalisation for the company's overall valuation and market capitalisation.
Optiscan Imaging Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Optiscan Imaging Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Optiscan Imaging Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Optiscan Imaging Ltd ranked by their cash flow conversion efficiency. Explore OIL cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Afyon Cimento Sanayi TAS
IS:AFYON
|
0.044x |
|
Laon People Inc.
KQ:300120
|
-0.276x |
|
Thai Optical Group Public Company Limited
BK:TOG
|
0.073x |
|
Chernan Metal Industrial
TWO:3631
|
0.004x |
|
Protech Mitra Perkasa Tbk PT
JK:OASA
|
-0.061x |
|
Binh Dien Fertilizer JSC
VN:BFC
|
0.226x |
|
SA Catana Group
PA:CATG
|
0.120x |
|
Zeotech Ltd
AU:ZEO
|
-0.080x |
Annual Cash Flow Conversion Efficiency for Optiscan Imaging Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Optiscan Imaging Ltd from 2001 to 2025. View Optiscan Imaging Ltd stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$7.71 Million ≈ $5.46 Million |
AU$-6.21 Million ≈ $-4.40 Million |
-0.806x | -94.45% |
| 2024-06-30 | AU$13.87 Million ≈ $9.81 Million |
AU$-5.74 Million ≈ $-4.06 Million |
-0.414x | +60.00% |
| 2023-06-30 | AU$3.04 Million ≈ $2.15 Million |
AU$-3.15 Million ≈ $-2.23 Million |
-1.035x | -78.07% |
| 2022-06-30 | AU$6.59 Million ≈ $4.66 Million |
AU$-3.83 Million ≈ $-2.71 Million |
-0.582x | -179.42% |
| 2021-06-30 | AU$10.22 Million ≈ $7.23 Million |
AU$-2.13 Million ≈ $-1.50 Million |
-0.208x | +76.93% |
| 2020-06-30 | AU$1.55 Million ≈ $1.10 Million |
AU$-1.40 Million ≈ $-988.16K |
-0.902x | -79.27% |
| 2019-06-30 | AU$2.82 Million ≈ $2.00 Million |
AU$-1.42 Million ≈ $-1.01 Million |
-0.503x | +30.68% |
| 2018-06-30 | AU$3.20 Million ≈ $2.27 Million |
AU$-2.32 Million ≈ $-1.64 Million |
-0.726x | +64.58% |
| 2017-06-30 | AU$1.67 Million ≈ $1.18 Million |
AU$-3.41 Million ≈ $-2.41 Million |
-2.049x | -401.67% |
| 2016-06-30 | AU$-749.65K ≈ $-530.43K |
AU$-509.25K ≈ $-360.32K |
0.679x | -91.85% |
| 2015-06-30 | AU$-175.21K ≈ $-123.97K |
AU$-1.46 Million ≈ $-1.03 Million |
8.331x | +125.11% |
| 2014-06-30 | AU$-184.66K ≈ $-130.66K |
AU$-683.39K ≈ $-483.54K |
3.701x | +395.39% |
| 2013-06-30 | AU$952.46K ≈ $673.92K |
AU$-1.19 Million ≈ $-844.31K |
-1.253x | +50.54% |
| 2012-06-30 | AU$313.31K ≈ $221.69K |
AU$-793.54K ≈ $-561.48K |
-2.533x | -625.77% |
| 2011-06-30 | AU$1.34 Million ≈ $950.06K |
AU$-468.58K ≈ $-331.55K |
-0.349x | +63.04% |
| 2010-06-30 | AU$1.30 Million ≈ $920.02K |
AU$-1.23 Million ≈ $-868.79K |
-0.944x | +47.97% |
| 2009-06-30 | AU$1.76 Million ≈ $1.24 Million |
AU$-3.19 Million ≈ $-2.26 Million |
-1.815x | -241.43% |
| 2008-06-30 | AU$7.70 Million ≈ $5.45 Million |
AU$-4.09 Million ≈ $-2.90 Million |
-0.532x | -180.52% |
| 2007-06-30 | AU$9.93 Million ≈ $7.03 Million |
AU$-1.88 Million ≈ $-1.33 Million |
-0.189x | +59.38% |
| 2006-06-30 | AU$10.31 Million ≈ $7.30 Million |
AU$-4.81 Million ≈ $-3.40 Million |
-0.466x | -56.00% |
| 2005-06-30 | AU$13.38 Million ≈ $9.47 Million |
AU$-4.00 Million ≈ $-2.83 Million |
-0.299x | +24.81% |
| 2004-06-30 | AU$12.90 Million ≈ $9.13 Million |
AU$-5.13 Million ≈ $-3.63 Million |
-0.398x | -1838.78% |
| 2003-06-30 | AU$16.18 Million ≈ $11.45 Million |
AU$-331.95K ≈ $-234.87K |
-0.021x | -132.24% |
| 2002-06-30 | AU$19.60 Million ≈ $13.87 Million |
AU$1.25 Million ≈ $882.24K |
0.064x | +120.59% |
| 2001-06-30 | AU$13.18 Million ≈ $9.33 Million |
AU$-4.07 Million ≈ $-2.88 Million |
-0.309x | -- |
About Optiscan Imaging Ltd
Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Germany, China, Australia, and the United States. It offers InVue, a microscopic medical imaging device for precision surgery; InForm, a digital pathology imaging device for pathology workflows;… Read more